A deal gives Vivos half of a test; reaching more than 325,000 patients still depends on agreements and court approval.

Stock Titan · 2026-10-19 · Neutral AI sentiment

A deal gives Vivos half of a test; reaching more than 325,000 patients still depends on agreements and court approval. Stock Titan

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。